Feed aggregator

Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases

Biospace news - Mon, 07/03/2023 - 02:00
Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases 3/7/2023

Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine

Biospace news - Mon, 07/03/2023 - 02:00
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine 3/7/2023

Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor

Biospace news - Mon, 07/03/2023 - 02:00
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor 3/7/2023

Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III

Biospace news - Mon, 07/03/2023 - 02:00
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III 3/7/2023

Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin

Biospace news - Mon, 07/03/2023 - 02:00
Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin 3/7/2023

AI Therapeutics Posts First Clinical Data for New ALS Mechanism

Biospace news - Sun, 06/04/2023 - 02:00
AI Therapeutics Posts First Clinical Data for New ALS Mechanism 4/6/2023

Hedge Fund Wages Proxy Battle with Exelixis Over R&D

Biospace news - Sun, 06/04/2023 - 02:00
Hedge Fund Wages Proxy Battle with Exelixis Over R&D 4/6/2023

NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful

Biospace news - Sun, 06/04/2023 - 02:00
NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful 4/6/2023

Pfizer Publishes Phase III RSV Data Ahead of May Decision

Biospace news - Sun, 06/04/2023 - 02:00
Pfizer Publishes Phase III RSV Data Ahead of May Decision 4/6/2023

How the IRA Will Affect Drug Development

Biospace news - Sun, 06/04/2023 - 02:00
How the IRA Will Affect Drug Development 4/6/2023

FDA Sets July Decision Date for Full Approval of Leqembi

Biospace news - Sat, 06/03/2023 - 02:00
FDA Sets July Decision Date for Full Approval of Leqembi 3/6/2023

Voyager Rolls on as Novartis Selects Two of Three CNS Targets

Biospace news - Sat, 06/03/2023 - 02:00
Voyager Rolls on as Novartis Selects Two of Three CNS Targets 3/6/2023

Full Results from Esperion's Cholesterol Drug Fail to Impress Investors

Biospace news - Sat, 06/03/2023 - 02:00
Full Results from Esperion's Cholesterol Drug Fail to Impress Investors 3/6/2023

Incyte Abandons Phase III Trial for Myelofibrosis Treatment

Biospace news - Sat, 06/03/2023 - 02:00
Incyte Abandons Phase III Trial for Myelofibrosis Treatment 3/6/2023

How to Nail Virtual Interviews & Networking Events

Biospace news - Sat, 06/03/2023 - 02:00
How to Nail Virtual Interviews & Networking Events 3/6/2023

FDA Action Alert: Roche and Acadia

Biospace news - Sat, 06/03/2023 - 02:00
FDA Action Alert: Roche and Acadia 3/6/2023

Bayer launches unit to develop new precision health consumer products

World Pharma News - Wed, 05/31/2023 - 10:00
The Consumer Health Division of Bayer has launched a business unit focused on developing new Precision Health products across its range of everyday health categories. Bayer will prioritize developing products that enable people to take greater control of their own personal health through digital solutions that facilitate more informed choices based on personal insights and novel delivery mechanisms.

AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study

Biospace news - Wed, 05/31/2023 - 02:00
AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study 5/31/2023

FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial

Biospace news - Wed, 05/31/2023 - 02:00
FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial 5/31/2023

Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody

Biospace news - Wed, 05/31/2023 - 02:00
Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody 5/31/2023